Journal of Cancer Research and Therapeutics Close
 

Figure 6: Inhibition of angiogenesis within tumors. CD31 immunohistochemistry showed the significant inhibition of angiogenesis within tumors by norcantharidin plus diamminedichloroplatinum (P < 0.05), (a) Normal saline, (b) diamminedichloroplatinum, (c) norcantharidin, (d) diamminedichloroplatinum plus norcantharidin, (e) microvessel density determined by counting the number of microvessels per high-power field in the sections stained with antibodies reactive to CD31 (n = 10)

Figure 6: Inhibition of angiogenesis within tumors. CD31 immunohistochemistry showed the significant inhibition of angiogenesis within tumors by norcantharidin plus diamminedichloroplatinum (<i>P</i> < 0.05), (a) Normal saline, (b) diamminedichloroplatinum, (c) norcantharidin, (d) diamminedichloroplatinum plus norcantharidin, (e) microvessel density determined by counting the number of microvessels per high-power field in the sections stained with antibodies reactive to CD31 (<i>n</i> = 10)